Target intelligence / Profile preview

Major tegument protein of Human cytomegalovirus (pp65) (pp65 (also known as UL83))

Target
pp65 (also known as UL83)
Molecular classification
Viral structural protein, Tegument protein, Other (not an enzyme, receptor, or human molecular family)
01

Overview

pp65 is the principal tegument protein of HCMV, constituting a significant portion of the virion mass[3]. Its key roles are as a structural scaffolding protein and as a "modulator" of the host immune response. It directly inhibits host antiviral signaling by blocking IRF-3 nuclear accumulation and interferon signaling[2][6], reduces NF-κB DNA-binding in infected cells, and interacts with NK cell receptors to suppress cytotoxicity[1][6]. pp65 is dispensable for viral replication in fibroblasts but is important for efficient replication in monocyte-derived macrophages[1]. As one of the most immunogenic HCMV antigens, pp65 is central to both cellular and humoral immune responses, and its presence is widely used for diagnosing and monitoring active HCMV infection in clinical practice via antigenemia assays and T cell response tests[2][4]. It is also under investigation as a target for HCMV vaccine development and adoptive T cell therapies[2][4][5].

Other names
pp65UL83HCMV pp65Human cytomegalovirus pp65CMV pp65
02

Mechanism of action

For therapies and monitoring: induction of protective T cell responses, antibody generation, monitoring via pp65 antigenemia assays in transplantation

03

Biological functions

Tegument stabilization and virion assemblyModulation of host immune responseInhibition of interferon signaling (specifically IRF-3 and NF-κB)Antigenic target for T cell responsesInterference with natural killer (NK) cell cytotoxicityDampening of type I interferon production
04

Disease associations

Infection (essential for HCMV immune evasion and pathogenicity)Other (major antigen for monitoring HCMV infection)
05

Safety considerations

Challenges include variability in immune response and difficulty in direct inhibition due to viral evasion mechanisms and intracellular locationNo notable toxicities attributed to pp65 itself, but immune therapies targeting pp65 (e.g., T cell infusions) must be carefully managed for possible immunopathology
06

Interacting drugs

No small-molecule drugs directly target pp65. However, it is a major target in vaccine development and immune monitoring strategies (e.g., adoptive transfer of pp65-specific T cells, pp65-based peptide vaccines)
07

Biomarkers

pp65 antigenemia (used for HCMV infection diagnosis, prognosis, and monitoring in immunosuppressed patients, especially transplant recipients)pp65-specific CD4 and CD8 T cell responses (measured in immune monitoring)

Beyond the preview

Go deeper on Major tegument protein of Human cytomegalovirus (pp65) (pp65 (also known as UL83)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major tegument protein of Human cytomegalovirus (pp65) (pp65 (also known as UL83)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call